Association of polymorphisms of the CYP1A1 and CYP1A2 cytochrome P450 genes with chronic obstructive pulmonary disease in Bashkortostan

Molecular Biology

Volumn 42, Issue 1, 2008, Pages 27-36

  Korytina, G F ^a   Akhmadishina, L Z ^a   Kochetova, O V ^a   Zagidullin, S Zh ^b   Victorova, T V ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Association; Chronic obstructive pulmonary disease; Cytochrome P450; Ethnic group

Indexed keywords

EID: 40849118326     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1007/s11008-008-1004-8     Document Type: Article

References (39)

1. Gichev Yu.P. 2002. Zagryaznenie okruzhayushchei sredy i zdorov'e cheloveka (Environmental Pollution and Human Health), Novosibirsk: Sib. Otd. Ross. Akad. Nauk.
2. www.goldcopd.com. GOLD Workshop Report: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2003.
3. Agusti A.G.N. 2005. COPD, a multicomponent disease: Implications for management. Respir. Med. 99, 670-682.
4. Brody J.S., Spira A. 2006. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3, 535-538.
5. Sandford A.J., Silverman E.K. 2002. Chronic obstructive pulmonary disease: 1. Susceptibility factors for COPD the genotype-environment interaction. Thorax. 57, 736-741.
6. Baranov, V.S., Baranova, E.V., Ivashchenko, T.E., Aseev, M.V., 2000. Genom cheloveka i geny predras polozhennosti (Human Genome and Predisposition Genes), St. Petersburg: Intermedika.
7. Sibiryak, S.V., Vakhitov, V.A., Kurchatova, N.N., 2003. Tsitokhrom R450 i immunnaya sistema: fakty, gipotezy, perspektivy (Cytochrome R450 and the Immune System: Facts, Hypotheses, and Prospects), Ufa: Gilem.
8. Lyakhovich V.V., Vavilin V.A., Zenkov N.K., Men'shchikova E.B. 2005. Activated oxygen metabolites in monooxygenase reactions. Byull. Sib. Otd. Ross. Akad. Med. Nauk. 118, 7-12.
9. Hukkanen J., Pelkonen O., Hakkola J., Raunio H. 2002. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 32, 391-411.
10. Spivack S.D., Hurteau G.J., Fasco M.J., Kaminsky L.S. 2003. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin. Cancer Res. 9, 6002-6011.
11. Persson I., Johansson I., Ingelman-Sundberg M. 1997. In vitro kinetics of two human CYP1A1variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun. 231, 227-230.
12. Bartsch H., Nair U., Risch A., et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev. 9, 3-28.
13. Smith G.B., Harper P.A., Wong J.M., et al. 2001. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: Impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomarkers Prev. 10, 839-853.
14. Murayama N., Soyama A., Saito Y., et al. 2004. Six novel nonsynonymous CYP1A2 gene polymorphism: Catalytic activites of the naturally occurring variant enzymes. J. Pharmacol. Exp. Therap. 308, 300-306.
15. www.imm.ki.se/CYPalleles/ Human Cytochrome P-450 (CYP) genes: A web page for the nomenclature of alleles.
16. Sachse C., Bhambra U., Smith G., et al. 2003. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: Allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br. J. Clin. Pharmacol. 55, 68-76.
17. Soyama A., Saito Y., Hanioka N., et al. 2005. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab. Pharmacokinet. 20, 24-33.
18. Zhang J.Y., Wang Y., Prakash C. 2006. Xenobioticmetabolizing enzymes in human lung. Curr. Drug Metab. 7, 939-948.
19. London S.J., Yuan J.M., Coetzee G.A., et al. 2000. CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai. China Cancer Epidemiol. Biomarkers Prev. 9, 987-991.
20. Nerurkar P.V., Okinaka L., Aoki C., et al. 2000. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol. Biomarkers Prev. 9, 1119-1122.
21. Alexandrie A.K., Nyberg F., Warholm M., Rannug A. 2004. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol, Biomarkers Prev. 13, 908-914.
22. Song N., Tan W., Xing D., Lin D. 2001. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis. 22, 11-16.
23. Budhi A., Hiyama K., Isobe T., et al. 2003. Genetic susceptibility for emphysematous changes of the lung in Japanese. Int. J. Mol. Med. 11, 321-329.
24. Garte S. 1998. The role of ethnicity in cancer susceptibility gene polymorphisms: The example of CYP1A1. Carcinogenesis. 19, 1329-1332.
25. Inoue K., Asao T., Shimada T. 2000. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica. 30, 285-295.
26. Hung R.J., Boffetta P., Brockmoller J., et al. 2003. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis. 24, 875-882.
27. Aklillu E., Carrillo J.A., Makonnen E., et al. 2003. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol. 64, 659-669.
28. Li D., Jiao L., Li Y., et al. 2006. Polymorphisms of cytochrome P450 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis. 27, 103-111.
29. Suryanarayana V., Deenadayal M., Singh L. 2004. Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in the South Indian population. Hum. Reprod. 19, 2648-2652.
30. Swofford L., Selander B. 1997. BIOSYS-2: Computer program for the analysis of allelic variation in genetics. Department of Genetics and Development, University of Illinois.
31. Xie X., Ott J. 1993. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 53, 1107.
32. BIOSTATISTICA, Primer of biostatistics version 4.03 by Stanton A. Glanz, McGrow Hill. 1998.
33. www.statistica.com StatSoft Inc., USA. Statistica v.6.0.
34. Garte S., Gaspari L., Alexandrie A.K., et al. 2001. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10, 1239-1248.
35. Hamdy S.I., Hiratsuka M., Narahara K., et al. 2003. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population. Br. J. Clin. Pharmacol. 55, 321-324.
36. Pavanello S., Pulliero A., Lupi S., et al. 2005. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat. Res. 10, 59-66.
37. Vavilin V.A., Makarova S.I., Lyakhovich V.V., Gavalov S.M. 2002. Association of polymorphic genes coding for xenobiotic biotransformation enzymes with predisposition to bronchial asthma in children with and without hereditary load. Genetika. 38, 539-545.
38. Korytina G.F., Yanbaeva D.G., Babenkova L.I., et al., 2005. Genetic polymorphisms in the cytochromes P450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to severe chronic lung disease in children. J. Mol. Med. 83, 700-710.
39. Pai G.V., Kuz'mina L.P., Kovchan O.V., et al. 2003. Genetic markers of occupational bronchopulmonary diseases: An example of polymorphic glutathione S-transferase M1 and cytochrome P-4501A1 genes. Med. Genet. 2, 223-226.